Literature DB >> 31710399

Substrate reduction therapy for GBA1-associated Parkinsonism: Are we betting on the wrong mouse?

Ellen Sidransky1, David Arkadir2,3, Peter Bauer4, Tama Dinur5, Grisel Lopez1, Arndt Rolfs4, Ari Zimran3,5.   

Abstract

Entities:  

Keywords:  zzm321990GBA1-associated parkinsonism; Gaucher carriers; Parkinson's disease; glucocerebrosidase; substrate reduction therapy

Mesh：

Substances：

Year:  2019        PMID： 31710399     DOI： 10.1002/mds.27903

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  3 in total

Review 1.  A patient with Gaucher disease and plasma cell dyscrasia: bidirectional impact.

Authors:  Ari Zimran; Rosa Ruchlemer; Shoshana Revel-Vilk
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 2.  Pro-cathepsin D, Prosaposin, and Progranulin: Lysosomal Networks in Parkinsonism.

Authors:  Nahid Tayebi; Grisel Lopez; Jenny Do; Ellen Sidransky
Journal:  Trends Mol Med       Date:  2020-09-15       Impact factor: 11.951

3.  Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm?

Authors:  Tama Dinur; Peter Bauer; Christian Beetz; Guido Kramp; Claudia Cozma; Marius-Ionuț Iurașcu; Michal Becker-Cohen; Majdolen Istaiti; Arndt Rolfs; Ari Zimran; Shoshana Revel-Vilk
Journal:  Int J Mol Sci       Date:  2022-01-30       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.